測試條市場規模、佔有率和成長分析（按產品類型、功能、應用、最終用戶和地區）- 產業預測，2025-2032 年

2023 年全球試紙市場規模價值 55 億美元，預計將從 2024 年的 60.2 億美元成長到 2032 年的 124.5 億美元，預測期內（2025-2032 年）的複合年成長率為 9.5%。

COVID-19 疫情大大重塑了全球試紙市場。儘管由於對感染傳播的擔憂，試紙的初始需求大幅下降，但對 COVID-19 診斷的研究和開發卻激增。同時，預計全球糖尿病和尿道感染（UTI）盛行率上升將在整個預測期內推動市場成長。世界衛生組織（WHO）預測，到2031年，糖尿病將成為第七大死因，尤其影響中低收入國家。人們對血糖值測試紙的認知和接受度不斷提高，使得患者能夠在家中進行自我測試（通常每天兩到三次），正在推動市場擴張。這些趨勢凸顯了不斷發展的醫療保健環境中對可訪問、高效的家庭檢測解決方案的迫切需求。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 宏觀經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術進步

試紙市場規模（依產品類型及複合年成長率） (2025-2032)

• 市場概況
• 血液試紙
• 尿液檢查
• 糖尿病條
• 螢光素
• 其他

試紙市場規模（按功能和複合年成長率） (2025-2032)

• 市場概況
• 視覺試紙
• 自動試紙

試紙市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概況
• 糖尿病
• 感染疾病
• 心臟標記檢測
• 妊娠和不孕症檢測
• 其他

測試條市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫院和診所
• 居家護理
• 診斷實驗室
• 其他

試紙市場規模（依地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Abbott Laboratories（USA）
• Acon Laboratories（USA）
• Arkray（Japan）
• B. Braun（Germany）
• Lifescan（USA）
• Roche（Switzerland）
• Siemens Healthineers（Germany）
• Tiadoc Technology（China）
• Teco Diagnostics（USA）
• Becton, Dickinson and Company（USA）
• Johnson & Johnson（USA）
• Bio-Rad Laboratories（USA）
• BioMerieux（France）
• Chembio Diagnostic Systems（USA）
• Nipro Corporation（Japan）
• PTS Diagnostics（USA）
• Quidel Corporation（USA）
• Trinity Biotech（Ireland）
• Wondfo Biotech（China）

結論和建議

Global Test Strip Market size was valued at USD 5.5 billion in 2023 and is poised to grow from USD 6.02 billion in 2024 to USD 12.45 billion by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).

The COVID-19 pandemic has significantly reshaped the global test strip market. Initially, the demand for test strips plummeted due to infection transmission concerns, but research and development in COVID-19 diagnostics have soared. Concurrently, the rising global prevalence of diabetes and urinary tract infections (UTIs) is expected to propel market growth throughout the forecast period. The World Health Organization projects diabetes will rank as the seventh-leading cause of death by 2031, particularly affecting low- and middle-income countries. Increasing awareness and acceptance of blood glucose test strips, which enable patients to self-test at home-typically 2-3 times daily-are driving their market expansion. This growing trend underscores the critical need for accessible and efficient at-home testing solutions in an evolving healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Test Strip market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Test Strip Market Segmental Analysis

Global Test Strip Market is segmented by Product Type, Function, Application, End User and region. Based on Product Type, the market is segmented into Blood Test Strips, Urine Test Strips, Diabetic Strips, Fluorescein and Others. Based on Function, the market is segmented into Visual Test Strips and Automated Test Strips. Based on Application, the market is segmented into Diabetes, Infectious Disease, Cardiac Marker Testing, Pregnancy & Fertility Testing and Others. Based on End User, the market is segmented into Hospitals & Clinics, Homecare, Diagnostic Labs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Test Strip Market

The global Test Strip market is significantly driven by the rising prevalence of diabetes worldwide, which is anticipated to fuel market expansion. As the cost of blood glucose test strips (BGTS) continues to garner attention, the traditional categorization of insulin users into a single homogenous group has led to regulations that limit consumption, such as the 8.2 strips per day allowed in provincial prescription insurance systems. Furthermore, the increasing number of diabetes patients will likely enhance market size, share, and revenue. In response to this growing demand, many companies are now providing home-care treatment options along with clear guidelines for caregivers, facilitating better management of diabetes.

Restraints in the Global Test Strip Market

The global test strip market faces significant restraints primarily due to inadequate reimbursement policies that hinder its growth potential. Several insurers have introduced quantity limitations on reimbursements, restricting the annual provision of blood glucose test strips (BGTS) to 400 for patients on hypoglycaemic medications and 200 for others. Furthermore, many insurers do not offer reimbursement for related medications, exacerbating the issue. The high cost of test strips also poses a challenge, making them unaffordable for low-income individuals. These factors collectively limit access and affordability, creating substantial barriers to market expansion and impacting patient care in managing diabetes effectively.

Market Trends of the Global Test Strip Market

The Global Test Strip market is witnessing significant growth, primarily driven by the rising prevalence of diabetes worldwide. As the number of diabetes cases continues to increase, there is an escalating demand for efficient blood glucose monitoring solutions. Test strips, integral to glucose meters, enable diabetic patients to manage their blood sugar levels effectively and conveniently. This trend is expected to dominate the market in the forecast period, with advancements in technology and increased awareness about diabetes management further propelling the adoption of test strips. As a result, stakeholders in the healthcare sector are focusing on innovations to enhance product availability and accuracy.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Test Strip Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Blood Test Strips
• Urine Test Strips
• Diabetic Strips
• Fluorescein
• Others

Global Test Strip Market Size by Function & CAGR (2025-2032)

• Market Overview
• Visual Test Strips
• Automated Test Strips

Global Test Strip Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diabetes
• Infectious Disease
• Cardiac Marker Testing
• Pregnancy & Fertility Testing
• Others

Global Test Strip Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Homecare
• Diagnostic Labs
• Others

Global Test Strip Market Size & CAGR (2025-2032)

• North America (Product Type, Function, Application, End User)
  • US
  • Canada
• Europe (Product Type, Function, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Function, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Function, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Function, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acon Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arkray (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifescan (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tiadoc Technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teco Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chembio Diagnostic Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PTS Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wondfo Biotech (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations